SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BISCAGLIA, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.353
AS - Asia 7.137
EU - Europa 3.641
SA - Sud America 1.219
AF - Africa 176
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 22.571
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.032
SG - Singapore 2.810
CN - Cina 1.548
BR - Brasile 953
VN - Vietnam 872
DE - Germania 744
IT - Italia 662
HK - Hong Kong 567
FI - Finlandia 394
GB - Regno Unito 380
FR - Francia 350
JP - Giappone 224
IN - India 214
TR - Turchia 212
PL - Polonia 210
UA - Ucraina 163
SE - Svezia 162
RU - Federazione Russa 159
ID - Indonesia 144
CA - Canada 138
MX - Messico 137
BD - Bangladesh 105
AR - Argentina 94
NL - Olanda 88
ZA - Sudafrica 79
ES - Italia 77
IQ - Iraq 64
CO - Colombia 44
PK - Pakistan 43
EC - Ecuador 41
AU - Australia 40
BE - Belgio 37
AT - Austria 36
KR - Corea 36
PH - Filippine 35
MY - Malesia 29
LT - Lituania 28
UZ - Uzbekistan 27
SA - Arabia Saudita 26
VE - Venezuela 26
EG - Egitto 25
IR - Iran 25
CH - Svizzera 22
CZ - Repubblica Ceca 17
IE - Irlanda 17
AE - Emirati Arabi Uniti 16
CL - Cile 16
MA - Marocco 15
TH - Thailandia 15
KE - Kenya 14
PY - Paraguay 12
TW - Taiwan 12
UY - Uruguay 12
IL - Israele 11
JO - Giordania 11
PE - Perù 11
PT - Portogallo 11
HR - Croazia 10
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
NP - Nepal 9
PS - Palestinian Territory 9
AL - Albania 8
DZ - Algeria 8
TN - Tunisia 8
CY - Cipro 7
DK - Danimarca 7
LB - Libano 7
NO - Norvegia 7
PA - Panama 7
RO - Romania 7
BH - Bahrain 6
CR - Costa Rica 6
ET - Etiopia 6
JM - Giamaica 6
KG - Kirghizistan 6
KW - Kuwait 6
MT - Malta 6
AZ - Azerbaigian 5
GE - Georgia 5
LV - Lettonia 5
SN - Senegal 5
BO - Bolivia 4
CI - Costa d'Avorio 4
EE - Estonia 4
GY - Guiana 4
NI - Nicaragua 4
OM - Oman 4
SI - Slovenia 4
BG - Bulgaria 3
BY - Bielorussia 3
CG - Congo 3
HN - Honduras 3
HU - Ungheria 3
LI - Liechtenstein 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
Totale 22.527
Salva come PNG Salva come JPEG
Città #
Singapore 1.689
Ashburn 1.626
San Jose 945
Fairfield 754
Woodbridge 563
Hong Kong 542
Beijing 488
Santa Clara 457
Houston 443
Munich 441
Chandler 334
Seattle 316
Ann Arbor 299
Wilmington 289
Ho Chi Minh City 288
Cambridge 265
Helsinki 259
Los Angeles 254
Dallas 246
New York 240
Tokyo 207
Warsaw 198
Jacksonville 185
Hanoi 182
Lauterbourg 144
Council Bluffs 141
São Paulo 121
Shanghai 106
Milan 97
Princeton 96
Izmir 95
London 91
Orem 91
Jakarta 86
Ferrara 83
Nanjing 82
Turku 71
Chicago 68
San Diego 67
Mexico City 66
Chennai 57
Atlanta 56
Frankfurt am Main 56
Brooklyn 52
Da Nang 47
Montreal 47
Stockholm 45
Buffalo 41
Denver 41
Johannesburg 40
Mumbai 39
Amsterdam 38
Boston 38
Haiphong 38
Brussels 37
Hefei 37
Nuremberg 37
Manchester 35
Poplar 35
Moscow 33
Boardman 32
Rio de Janeiro 31
Toronto 31
Phoenix 30
Tianjin 30
Bremen 29
Bologna 28
Falls Church 28
San Francisco 27
Salt Lake City 26
Rome 24
Tashkent 24
Ankara 23
Paris 23
The Dalles 23
Nanchang 22
Quito 21
Melbourne 20
New Delhi 20
Columbus 19
Redwood City 19
Belo Horizonte 18
Des Moines 18
Guangzhou 18
Lappeenranta 18
Baghdad 17
Shenyang 17
Shenzhen 17
Washington 17
Biên Hòa 16
Changsha 16
Jiaxing 16
Norwalk 16
Querétaro 16
Schiffdorf 16
Dong Ket 15
Jeddah 15
Redondo Beach 15
Bangkok 14
Cairo 14
Totale 14.703
Salva come PNG Salva come JPEG
Nome #
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 422
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 416
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 367
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 354
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 323
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 301
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 283
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 277
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 277
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 274
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 260
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 259
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 258
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 255
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 249
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 246
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 242
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 237
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 236
Reperfusion Damage - A Story of Success, Failure, and Hope 225
Uric acid and coronary artery disease: An elusive link deserving further attention 224
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 218
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 217
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 213
Angina and left ventricular dysfunction: can we "reduce' it? 213
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 211
BRS implantation in long lesions requiring device overlapping: Myth or reality? 211
Can we improve myocardial protection during ischaemic injury? 211
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 210
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 207
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 204
Fractional flow reserve: Current applications and overview of the available data 199
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 199
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 197
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 196
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 194
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 193
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 191
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 188
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 188
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 188
Angina and chronic obstructive pulmonary disease: facing the perfect storm 186
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 180
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 180
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 179
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 173
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 173
Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy 172
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 172
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 171
Fractional flow reserve implementation in daily clinical practice: A European survey 169
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 169
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 168
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 168
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 166
"Safe Femoral" Artery Approach in Endovascular Procedures: A Systematic Review of Its Safety and Feasibility 165
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 161
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry 160
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 159
QFR for the Revascularization of Nonculprit Vessels in MI Patients: Insights From the FIRE Trial 159
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 158
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 158
Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis: A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) 152
Coronary Computed Tomography Angiography for the Assessment of Sirolimus-Eluting Resorbable Magnesium Scaffold 151
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 150
Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19 147
Clinical Outcome of FFR-Guided Revascularization Strategy of Coronary Lesions: The HALE-BOPP Study 147
Transradial coronary catheterization and intervention across the whole spectrum of Allen test results 146
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 146
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 144
Age and Outcomes in TAVR Patients: Are We Barking Up the Wrong Tree? 143
#FullPhysiology: a systematic step-by-step guide to implement intracoronary physiology in daily practice 142
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 142
Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system 139
Remodelling after an Infarct: Crosstalk between Life and Death 139
Enhanced stent visualization systems during PCI: A case series and review of literature 139
30-Day DAPT in Patients at High Bleeding Risk Undergoing PCI With Biodegradable-Polymer Sirolimus-Eluting Ultra-Thin Stent 137
Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease 137
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) Registry 133
Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study 132
Functional Assessment and Acute Coronary Syndrome 132
Neural interfaces to monitor Interventional Cardiologists' mental workload: GAME-ON SAGA 132
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 128
Complete vs. culprit-only strategy in older MI patients with multi-vessel disease 127
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 127
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial 126
Seven french radial artery access for PCI: A prospective single-center experience 125
Comparison of quantitative flow ratio, Pd/Pa, and diastolic hyperaemia-free ratio vs. fractional flow reserve in non-culprit lesion of patients with non-ST-segment elevation myocardial infarction 125
Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies 124
Extracorporeal Circulatory Support in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis 122
The impact of periprocedural myocardial infarction on mortality in older adults with non-ST-segment elevation acute coronary syndrome: a pooled analysis of the FRASER and HULK studies 120
Complete versus culprit-only strategy in older MI patients with multivessel disease 119
CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR THE ASSESSMENT OF SIROLIMUS-ELUTING RESORBABLE MAGNESIUM SCAFFOLD 118
Meta-Analyses on DAPT Length: Chasing the Calm After the (Perfect) Storm 118
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical Trial 114
Multidomain Rehabilitation for Older Patients with Myocardial Infarction 114
What are the recommendations for adding novel oral anticoagulants to P2Y12-receptor inhibitors, with or without aspirin? 113
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 112
Combined use of intra-aortic balloon pump and impella in cardiogenic shock: A systematic review 111
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction With or Without ST-Segment Elevation 111
Totale 18.563
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021285 0 0 0 0 0 0 0 0 0 0 192 93
2021/20221.041 106 96 78 43 46 58 56 72 45 78 124 239
2022/2023876 105 55 50 69 128 120 69 72 120 8 58 22
2023/2024899 48 68 36 19 64 147 53 96 23 59 76 210
2024/20254.596 112 104 281 238 507 449 338 270 820 451 565 461
2025/202611.233 1.045 464 1.003 1.403 1.663 764 1.351 717 1.312 1.454 57 0
Totale 23.045